Zhiguo Luo

机构：Hubei University of Medicine, Fudan University Shanghai Cancer Center

发表论文 15 篇 · 总被引 93 次 · h-index 3

代表论文

• Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma (2008 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 72)
• Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma (2024 · Aging · 被引 5)
• Abstract CT208: Tebotelimab, a PD-1/LAG-3 bispecific antibody, in patients with untreated, unresectable, recurrent or metastatic, mucosal melanoma: An open-label, single-arm, Phase 1 study (2023 · Cancer Research · 被引 4)
• Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study (2024 · The Oncologist · 被引 3)
• Advanced Breast Angiosarcoma Completely Responding to Gemcitabine-Containing Chemotherapy (2012 · Breast Care · 被引 3)
• P-172 A multi-center, open-label, randomized controlled trial of nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine for first-line treatment of advanced pancreatic cancer (PC) (2022 · Annals of Oncology · 被引 2)